Case reports in oncology · 2025
Recurrent High-Risk Neuroblastoma in an Adult Woman 28 Years following Curative Treatment.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mistry Hetal, Kritselis Michael, Fridley Jared S, Punsoni Michael, DeNardo Bradley, Wong Eric T
Аннотация
INTRODUCTION: Neuroblastoma is a common pediatric solid tumor that frequently presents with high-risk disease.
CASE PRESENTATION: An adult woman with a remote history of childhood neuroblastoma at age two presented to the hospital with spinal cord compression. She was ultimately diagnosed with metastatic neuroblastoma 28 years following her initial diagnosis. The patient had previously been in sustained remission, was functional and actively working, and had undergone follow-up in a cancer survivorship clinic. To our knowledge, this is the longest reported period from remission of neuroblastoma to recurrence, as the patient was well into adulthood at the time of diagnosis. Moreover, she presented with florid disease, characterized by diffuse osseous, solid organ involvement, and progressive cytopenia. She was treated with chemotherapy but developed multiple complications.
CONCLUSION: This report illustrates an exceptionally rare late presentation of recurrent high-grade neuroblastoma, treatment course, and clinical outcome.
CASE PRESENTATION: An adult woman with a remote history of childhood neuroblastoma at age two presented to the hospital with spinal cord compression. She was ultimately diagnosed with metastatic neuroblastoma 28 years following her initial diagnosis. The patient had previously been in sustained remission, was functional and actively working, and had undergone follow-up in a cancer survivorship clinic. To our knowledge, this is the longest reported period from remission of neuroblastoma to recurrence, as the patient was well into adulthood at the time of diagnosis. Moreover, she presented with florid disease, characterized by diffuse osseous, solid organ involvement, and progressive cytopenia. She was treated with chemotherapy but developed multiple complications.
CONCLUSION: This report illustrates an exceptionally rare late presentation of recurrent high-grade neuroblastoma, treatment course, and clinical outcome.